SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1

Ana Cuenda, John Rouse, Yair N. Doza, Roger Meier, Philip Cohen (Lead / Corresponding author), Timothy F. Gallagher, Peter R. Young, John C. Lee

    Research output: Contribution to journalArticle

    1899 Citations (Scopus)

    Abstract

    A class of pyridinyl imidazoles inhibit the MAP kinase homologue, termed here reactivating kinase (RK) [Lee et al. (1994) Nature 372, 739–746]. We now show that one of these compounds (SB 203580) inhibits RK in vitro (IC50 = 0.6 ?M), suppresses the activation of MAPKAP kinase-2 and prevents the phosphorylation of heat shock protein (HSP) 27 in response to interleukin-1, cellular stresses and bacterial endotoxin in vivo. These results establish that MAPKAP kinase-2 is a physiological RK substrate, and that HSP27 is phosphorylated by MAPKAP kinase-2 in vivo. The specificity of SB 203580 was indicated by its failure to inhibit 12 other protein kinases in vitro, and by its lack of effect on the activation of RK kinase and other MAP kinase cascades in vivo. We suggest that SB 203580 will be useful for identifying other physiological roles and targets of RK and MAPKAP kinase-2.
    Original languageEnglish
    Pages (from-to)229-233
    Number of pages5
    JournalFEBS Letters
    Volume364
    Issue number2
    DOIs
    Publication statusPublished - 8 May 1995

    Fingerprint

    Interleukin-1
    Phosphotransferases
    HSP27 Heat-Shock Proteins
    Imidazoles
    MAP Kinase Kinase Kinases
    MAP Kinase Signaling System
    Endotoxins
    Chemical activation
    Protein Kinases
    Inhibitory Concentration 50
    Phosphorylation
    SB 203580
    MAP-kinase-activated kinase 2
    Substrates
    In Vitro Techniques

    Keywords

    • MAP kinase
    • Protein kinase inhibitor
    • Cytokine
    • Osmotic stress
    • LPS
    • HSP27

    Cite this

    Cuenda, Ana ; Rouse, John ; Doza, Yair N. ; Meier, Roger ; Cohen, Philip ; Gallagher, Timothy F. ; Young, Peter R. ; Lee, John C. / SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. In: FEBS Letters. 1995 ; Vol. 364, No. 2. pp. 229-233.
    @article{587f2afafb544a1c8ee43e08e50ff08f,
    title = "SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1",
    abstract = "A class of pyridinyl imidazoles inhibit the MAP kinase homologue, termed here reactivating kinase (RK) [Lee et al. (1994) Nature 372, 739–746]. We now show that one of these compounds (SB 203580) inhibits RK in vitro (IC50 = 0.6 ?M), suppresses the activation of MAPKAP kinase-2 and prevents the phosphorylation of heat shock protein (HSP) 27 in response to interleukin-1, cellular stresses and bacterial endotoxin in vivo. These results establish that MAPKAP kinase-2 is a physiological RK substrate, and that HSP27 is phosphorylated by MAPKAP kinase-2 in vivo. The specificity of SB 203580 was indicated by its failure to inhibit 12 other protein kinases in vitro, and by its lack of effect on the activation of RK kinase and other MAP kinase cascades in vivo. We suggest that SB 203580 will be useful for identifying other physiological roles and targets of RK and MAPKAP kinase-2.",
    keywords = "MAP kinase, Protein kinase inhibitor, Cytokine, Osmotic stress, LPS, HSP27",
    author = "Ana Cuenda and John Rouse and Doza, {Yair N.} and Roger Meier and Philip Cohen and Gallagher, {Timothy F.} and Young, {Peter R.} and Lee, {John C.}",
    year = "1995",
    month = "5",
    day = "8",
    doi = "10.1016/0014-5793(95)00357-F",
    language = "English",
    volume = "364",
    pages = "229--233",
    journal = "FEBS Letters",
    issn = "0014-5793",
    publisher = "Wiley",
    number = "2",

    }

    SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. / Cuenda, Ana; Rouse, John; Doza, Yair N.; Meier, Roger; Cohen, Philip (Lead / Corresponding author); Gallagher, Timothy F.; Young, Peter R.; Lee, John C.

    In: FEBS Letters, Vol. 364, No. 2, 08.05.1995, p. 229-233.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1

    AU - Cuenda, Ana

    AU - Rouse, John

    AU - Doza, Yair N.

    AU - Meier, Roger

    AU - Cohen, Philip

    AU - Gallagher, Timothy F.

    AU - Young, Peter R.

    AU - Lee, John C.

    PY - 1995/5/8

    Y1 - 1995/5/8

    N2 - A class of pyridinyl imidazoles inhibit the MAP kinase homologue, termed here reactivating kinase (RK) [Lee et al. (1994) Nature 372, 739–746]. We now show that one of these compounds (SB 203580) inhibits RK in vitro (IC50 = 0.6 ?M), suppresses the activation of MAPKAP kinase-2 and prevents the phosphorylation of heat shock protein (HSP) 27 in response to interleukin-1, cellular stresses and bacterial endotoxin in vivo. These results establish that MAPKAP kinase-2 is a physiological RK substrate, and that HSP27 is phosphorylated by MAPKAP kinase-2 in vivo. The specificity of SB 203580 was indicated by its failure to inhibit 12 other protein kinases in vitro, and by its lack of effect on the activation of RK kinase and other MAP kinase cascades in vivo. We suggest that SB 203580 will be useful for identifying other physiological roles and targets of RK and MAPKAP kinase-2.

    AB - A class of pyridinyl imidazoles inhibit the MAP kinase homologue, termed here reactivating kinase (RK) [Lee et al. (1994) Nature 372, 739–746]. We now show that one of these compounds (SB 203580) inhibits RK in vitro (IC50 = 0.6 ?M), suppresses the activation of MAPKAP kinase-2 and prevents the phosphorylation of heat shock protein (HSP) 27 in response to interleukin-1, cellular stresses and bacterial endotoxin in vivo. These results establish that MAPKAP kinase-2 is a physiological RK substrate, and that HSP27 is phosphorylated by MAPKAP kinase-2 in vivo. The specificity of SB 203580 was indicated by its failure to inhibit 12 other protein kinases in vitro, and by its lack of effect on the activation of RK kinase and other MAP kinase cascades in vivo. We suggest that SB 203580 will be useful for identifying other physiological roles and targets of RK and MAPKAP kinase-2.

    KW - MAP kinase

    KW - Protein kinase inhibitor

    KW - Cytokine

    KW - Osmotic stress

    KW - LPS

    KW - HSP27

    U2 - 10.1016/0014-5793(95)00357-F

    DO - 10.1016/0014-5793(95)00357-F

    M3 - Article

    VL - 364

    SP - 229

    EP - 233

    JO - FEBS Letters

    JF - FEBS Letters

    SN - 0014-5793

    IS - 2

    ER -